Design and investigation of multivalent ligands for the detection and treatment of diseases
Victor J. Hruby
Structure-based drug discovery for gpcrs: From receptors to ligands
Alexander Heifetz and Richard Law
James K. Bashkin
Xiaoqi Chen
Larry Wilson
Understanding the essential requirements for success in structure-based design
Gregory L. Warren
Alexander D. MacKerell
Computer-aided design of glucokinase activators
Meihua Tu
Jetze J. Tepe
William H. Bisson
Seetharama D. Satyanarayanajois
Concepcion Gonzalez-Bello
Design and synthesis of novel pyrimidone analogues as HIV-1 integrase inhibitors
Guisen Zhao, Shenghui Yu, Tino Wilson Sanchez and Nouri Neamati
Synthesis and anti-candida activity evaluation of new [1,2,4] triazolo[3,4-b][1,3,4] thiadiazines
Mashooq Ahmad Bhat
Newer approaches to the discovery of glitazones
Praveen Thaggikuppe Krishnamurthy
New approaches to “hit” optimization
Istvan J. Enyedy
Colin McMartin and Regine S. Bohacek
Integrating computational approaches into high throughput screening for rational drug discovery
Xin Hu
Regine S. Bohacek and McMartin C
Nicolas Moitessier
Kal Ramnarayan
Discovery of highly-potent and selective inhibitors for the ABCG2 transporter
Ahcène Boumendjel
Predictive application of bioisostere transformations to identify novel high quality compound ideas
Matthew Segall, James Chisholm, John Barnard, Julian Hayward, Edmund Champness, Chris Leeding, Hector Garcia and Iskander Yusof
Novel sildenafil analogues: Possible drugs for increased sensitivity to chemotherapuetic agents
Aina Westrheim Ravna
Alessandra Nurisso
Alexander V. Maksimenko and Robert S. Beabealashvili
In silico screening for anti-HPV agents using docking studies
Tatsuya Takagi and Norihito Kawashita
Cesar M. Compadre
New polymeric “ruthenium-cyclopentadienyl” complexes for drug delivery in cancer therapy
Andreia Valente, M. Helena Garcia, Fernanda Marques and Philippe Zinck
Unravelling the human multidrug resistance P-glycoprotein poly-specificity
Pierre Falson, Lorena Martinez, Ophélie Arnaud, Emilie Henin, Vincent Chaptal, RupakDoshi, HochaoTao, Michel Tod, Attilio di Pietro, Qinghai Zhang and Geoffrey Chang
PK modulation of haptenylated peptides via non-covalent antibody complexation
Stefan Deng
Fazlul Huq
Designed monofunctional platinums found to have significant antitumor activity
Laila Arzuman
A phytochemical and biological investigation of Aloe grandidentata Salm-Dyck
Taghreed A. Ibrahim, Nabawya M. EL Fiki, Ibrahim A. Shehata, Amany A. Sleem and Mouchira M. Shoukry
Vaishali M. Patil, Neeraj Masand, V. K. Sharma and S. P. Gupta
Innovative approaches to expand medicinal chemistry space
Gerard Rosse
James Hendrix, Dmitri Rebatchouk and Felix Sheinerman
Discovery of a small molecule direct keap1-Nrf2 inhibitor as an anti-oxidant inflammation modulator
Magesh Sadagopan
Can cubane act as a benzene isostere?
Craig M. Williams and G. Paul Savage
Mitsuji Yamashita, Reiko Makita, Michio Fujie, Satoki Nakamura, Mayumi Yamaoka1, Manabu Yamada1, Junko Yamashita, Tatsuo Oshikawa, Kazuhide Asai, Taishi Niimi, Takuya Suyama, Mitsuo Toda, Yasutaka Tanaka, Motohiko Kimura, Haruhiko Sugimura and Kazunori Ohnishi
G. Lassalle, C. Alcouffe, C. Herbert, M. Bianciotto1, P.A. Driguez, J. Gabriel, P. Fons, F. De Smet, P. Carmeliet, U. Schieborr, K. Saxena, H. Schwalbe, F.L. Gervasio, T. Blundell, J.P. Herault, J.M. Herbert1 and F. Bono
Yue-Wei Guo
On the field of metallodrugs -new ruthenium compounds as anti-tumor agents
Ana Isabe Tomaz, Fernanda Marques, António P. Matos, Rodrigo F. M. de Almeida and M. Helena Garcia
S.Samanta, S.Prakash, D. Maji and R.K.Shina
Synthesis and screening of newer quinazolin-3(H)-4-one derivatives for anticonvulsant activity
Jayasekhar P Nair and Mincy Mathew
Drug profile matching- drug discovery by polypharmacology-based interaction profiling
Zoltan Simon, Agnes Peragovics, Balazs Jelinek, Pal Czobor, Istvan Bitter, Peter Hari and Andras Malnasi-Csizmadia
Novel structural elements for drug discovery: Identification, synthesis and application
Pavel Mykhailiuk
Synthesis and evaluation of some novel thiazolidinedione derivatives as PPAR-α/γ dual agonists
Praveen Thaggikuppe Krishnamurthy
Carsten Detering
Purushottamachar Puranik, Andrew Kwegyir-Afful, David McCarty, Lalji Gediya, Hannah Mbatia and Vincent C.O. Njar
Synthesis of privileged structure libraries for biological evaluation
John Spencer
Jean Leandro dos Santos
Osadolor H. B, Igharo O. G, Okuo R. O and Anukam K. C
Lipid pattern in serum of patients with type 2 diabetes mellitus
Ashur S, Eljamil, Khaled Ammar Elnakaa, Salma Elmaradi
What can we expect from new therapeutic strategies in nano-pharmacology and nanomedicine?
Hans-Christian Siebert
Gjumrakch Aliev
The Hsp90 C-terminal binding site, instructions for and ramifications of inhibition
Brian S. J. Blagg
Thota Ganesh
Selective vitamin K2 biosynthesis inhibitors to treat non-replicating Mycobacterium tuberculosis
Michio Kurosu
Inhibitors of fatty acid amide hydrolase (FAAH): SAR and results in pre-clinical pain models
J. Guy Breitenbucher
Prabagaran Narayanasamy
The synthesis of potential inhibitors of panthothenate synthetase
Kellie L. Tuck
Design and synthesis of inhibitors of cysteine protease γ-glutamyl hydrolase
Debatosh Majumdar
Inward rectifier potassium channels as emerging drug targets
Jerod S. Denton
Ashutosh Kumar, Akihiro Ito, Misao Yoneyama, Minoru Yoshida and Kam Y. J. Zhang
Keiko Ikemoto
C. Gopi Mohan
Nils Hansen
Ibrahim Chikowe
Medicinal Chemistry received 6627 citations as per Google Scholar report